Aurora Cannabis Inc. Reports on the Results of 2025 Annual Shareholder Meeting
On August 8, 2025, Aurora Cannabis Inc., a prominent player in the global medical cannabis sector based in Canada, held its Annual General and Special Meeting of Shareholders. Conducted via a virtual webcast, the meeting revealed that 17,736,521 common shares were represented, signifying 31.53% participation from its outstanding shares.
During the meeting, shareholders had the crucial task of voting on the election of directors, and the results were notably significant. Miguel Martin received a majority of votes with 5,513,929 votes in favor, while Michael Singer garnered 5,194,307 votes. Other nominees included Chitwant Kohli and Norma Beauchamp, who also received substantial support, ensuring their election to the Board of Directors. However, Theresa Firestone, who had served on the Board since 2021 and held the chair position for the Human Resources and Compensation Committee, faced a different fate—after revealing insufficient support, she announced her resignation, which will take effect on August 31, 2025.
Both Miguel Martin, the Executive Chairman, and Michael Singer, appointed as the new Lead Independent Director, expressed gratitude for Firestone's contributions over her four-year tenure. In their statements, they recognized her wealth of knowledge and commitment, which significantly influenced Aurora's strategic direction. Following the meeting, attention shifted to filling the vacancy left by Firestone, with the Nominating and Corporate Governance Committee tasked to seek a suitable candidate.
During the meeting, shareholders also voted to reappoint Ernst & Young LLP as the Company's auditors. Additionally, amendments to the Company's RSU Plan, PSU Plan, and Share Option Plan were approved. Yet, a non-binding advisory vote regarding executive compensation—a 'say-on-pay' measure—did not achieve the majority support required for approval.
Aurora Cannabis prides itself on being a pioneer in the medical cannabis industry, serving both medical and consumer segments across multiple regions, including Canada, Europe, Australia, and New Zealand. The company’s diverse portfolio boasts notable adult-use brands such as Drift and San Rafael '71, alongside medical brands like MedReleaf and Whistler Medical Marijuana Co. Furthermore, Aurora maintains a significant stake in Bevo Farms Ltd., a prominent supplier of propagated agricultural plants in North America.
With a commitment to restoring health and enhancing lives through cannabis use, Aurora continues to focus on innovation and the quality of its products. It is reassuring for stakeholders that the integration of new board members and the ongoing investments in corporate governance will likely facilitate robust growth and strong financial performance amid evolving market dynamics.
As the future unfolds, investors and industry observers will keenly watch how Aurora navigates these changes and seizes opportunities in an ever-expanding landscape of medical cannabis.
For additional information about Aurora, stakeholders can visit their official website at www.auroramj.com. The Company’s shares are publicly traded on NASDAQ and TSX under the symbol 'ACB.'